Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Laryngol Otol ; 134(12): 1123-1127, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33190655

ABSTRACT

BACKGROUND: Olfactory dysfunction represents one of the most frequent symptoms of coronavirus disease 2019, affecting about 70 per cent of patients. However, the pathogenesis of the olfactory dysfunction in coronavirus disease 2019 has not yet been elucidated. CASE REPORT: This report presents the radiological and histopathological findings of a patient who presented with anosmia persisting for more than three months after infection with severe acute respiratory syndrome coronavirus-2. CONCLUSION: The biopsy demonstrated significant disruption of the olfactory epithelium. This shifts the focus away from invasion of the olfactory bulb and encourages further studies of treatments targeted at the surface epithelium.


Subject(s)
Anosmia/etiology , COVID-19/complications , Olfaction Disorders/physiopathology , Olfactory Mucosa/pathology , Anosmia/diagnosis , Anosmia/drug therapy , Anosmia/virology , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/virology , Cortisone/administration & dosage , Cortisone/therapeutic use , Female , Humans , Magnetic Resonance Imaging/methods , Middle Aged , Olfactory Bulb/diagnostic imaging , Olfactory Mucosa/virology , SARS-CoV-2/genetics , Treatment Outcome
2.
AJR Am J Roentgenol ; 182(6): 1505-12, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15149997

ABSTRACT

OBJECTIVE: The aim of this study was to characterize focal hepatic lesions using agent detection imaging and Levovist. MATERIALS AND METHODS: Sixty-five patients (21 male and 44 female; age range, 8-82 years; mean +/- standard deviation, 58.1 +/- 14.5 years) were independently evaluated by two observers in a blinded manner using stored sonographic images. Seventy-five lesions were found: 15 hepatocellular carcinomas, nine focal nodular hyperplasias, two adenomas, 21 hemangiomas, 23 metastases, and five regenerative nodules. Nine patients were excluded (six because of technical failures, three with unproven diagnoses). New high-mechanical-index software was used to reveal power harmonic responses from contrast microbubble destruction. After a venous bolus injection of 4 g of Levovist at a strength of 400 mg/mL, delayed imaging was used to study lesion enhancement in the arterial, portal, and parenchymal phases. Two comparisons were made. The first was between the B-mode image and the first contrast-enhanced image after the flash. The second was between color Doppler sonograms and real-time contrast-enhanced perfusion images. RESULTS: Contrast-enhanced images after the flash and real-time contrast-enhanced images revealed more information for the characterization of the lesion than did gray-scale and color Doppler images (p < 0.0001, Wilcoxon's signed rank test). Different types of lesions showed statistically significant differences in enhancement during each of the three vascular phases (p < 0.005, Kruskal-Wallis test). Lesions with lower contrast enhancement were metastases and regenerating nodules. Good agreement was present between the two observers; differences were not statistically significant (p > 0.05). CONCLUSION: Agent detection imaging with Levovist increased diagnostic confidence in the characterization of focal hepatic lesions as compared with standard sonography.


Subject(s)
Contrast Media , Liver Neoplasms/diagnostic imaging , Polysaccharides , Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Observer Variation , Single-Blind Method , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...